ReviewFrontiers in toxicology2025
Forensic toxicology of benzodiazepines: neuropharmacological effects, analytical challenges, and emerging detection strategies.
Review in Frontiers in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Investigation and Implementation of Analyte Protectants in the Gas Chromatography-Tandem Mass Spectrometry Analysis of Benzodiazepines and Opioids in Whole Blood Extracts.Journal of separation science · 2026Article
- Review
- The Real-World Safety Profile of Temazepam: A 20-Year Pharmacovigilance Analysis Based on the Large-Scale FAERS Database.CNS neuroscience & therapeutics · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing misuse of benzodiazepines (BZDs) in drug-facilitated crimes (DFCs) has become a serious concern for forensic experts, healthcare professionals, and legal authorities. These drugs, which are commonly prescribed for anxiety and sleep disorders, are also used to commit crimes such as sexual assault and robbery. Their sedative and memory-blocking effects render them particularly dangerous. One of the biggest challenges is that BZDs are rapidly broken down in the body, limiting the time available for detection. This creates major problems in forensic investigations and reduces the chance of holding offenders accountable for their actions. In addition, memory loss caused by BZDs often affects a victim's ability to recall events, making legal cases more challenging. This review aims to comprehensively synthesize the current knowledge on the use of BZDs in DFCs, their neuropharmacological mechanisms, and the challenges associated with their detection. It also discusses legal issues and emerging forensic tools that may help overcome the current limitations. By addressing this issue from medical, forensic, and legal perspectives, this review aims to recommend better prevention strategies, more effective investigations, and stronger legal outcomes for cases involving benzodiazepine-facilitated crimes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.